Clinical Trial Update: A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating SBRT for squamous cell carcinoma of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasms
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• SBRT (stereotactic body radiotherapy)

Snippet

Sponsor: McMaster University | Conditions: Head and Neck Neoplasms, Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN